Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Biological Research

Fig. 2

From: Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival

Fig. 2

Percentage of cell death of AGS R-CDDP cells exposed to MVC and/or CDDP. The results include annexin V-positive/PI-negative cells at Q4 coordinate, annexin V/PI double-positive cells at Q2, and annexin V-negative/PI-positive cells at Q1. Cells were incubated for 72 h with MVC and/or CDDP, and the cell death was measured by flow cytometry. The fluorescence was read at maximum excitation/emission of 499⁄521 for Alexa Fluor 488 annexin V and 535⁄617 for PI. Kruskal-Wallis with Dunn post-hoc test was used to compare groups. Values of P ≤ 0.05 were considered statistically significant. ***P < 0.001 and ****P < 0.0001. Data were expressed as mean ± SD of three biological replicates. Maraviroc (MVC) and Cisplatin (CDDP)

Back to article page